Named on one round in the feed.
Since 2024-12-03
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Orakl Oncology A French TechBio company using AI and real patient biology to predict how cancer drugs will perform in clinical trials | Seed Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | €15M financing total | 2024-12-03 | [ PART ] |